Electromed Inc (ELMD) 1.45 $ELMD
Electromed reports planned departure of board member Darrel Kloeckner
M2 - Fri May 23, 5:34AM CDT
Electromed (NYSE MKT:ELMD), which manufactures, markets, and sells products that provide airway clearance therapy to patients with compromised pulmonary function, disclosed on Thursday that its board member Darrel Kloeckner will not stand for re-election at its 2014 Annual Meeting of Shareholders.
Electromed, Inc. Board Member Announces Plans to Step Down from Board
Business Wire - Thu May 22, 4:00PM CDT
Electromed, Inc. (NYSE MKT: ELMD) announced today that Darrel Kloeckner, a member of the Company's Board of Directors will not stand for reelection at the Company's 2014 Annual Meeting of Shareholders. Mr. Kloeckner has been a member of the Board since 2010.
Electromed, Inc. Reports Fiscal Year 2014 Second Quarter Results
Business Wire - Tue Feb 11, 8:00AM CST
Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the Company's second quarter of fiscal 2014.
Rudolph Technologies to Present at the Stifel Technology, Internet & Media Conference 2014
Business Wire - Tue Feb 04, 6:00AM CST
Rudolph Technologies, Inc. (NYSE: RTEC), a leading provider of process characterization equipment, lithography equipment and software for wafer fabs and advanced packaging facilities, today announced that the Company will present at the Stifel Technology, Internet & Media Conference 2014 at the Fairmont Hotel in San Francisco on February 11, 2014 at 9:10 am Pacific Standard Time. Steven Roth, Chief Financial Officer, will provide an overview of the Company and will discuss its competitive position and future prospects.
Electromed Down 10.5%, Shares Slide into the Red (ELMD)
Comtex SmarTrend(R) - Mon Jan 06, 11:44AM CST
Electromed (AMEX:ELMD) is one of today's worst performing low-priced stocks, down 10.5% to $2.30 on 1.1x average daily volume. Electromed has traded 322,000 shares thus far today, vs. average volume of 297,000 shares per day. The stock has underperformed the Dow (-10.5% to the Dow's -0.2%) and underperformed the S&P 500 (-10.5% to the S&P's -0.3%) during today's trading.
Electromed's SmartVest SQL receives US FDA market clearance
M2 - Tue Dec 31, 4:48AM CST
Electromed Inc (NYSE MKT: ELMD), a medical device company, on Monday announced that it has been notified by the US Food and Drug Administration that its next generation SmartVest Airway Clearance System, the model SQL, has been cleared to market.
Electromed, Inc. Receives FDA Market Clearance for the SmartVest(R) SQL(TM)
Business Wire - Mon Dec 30, 8:00AM CST
Electromed, Inc. (NYSE MKT: ELMD), a global medical device company, today announced it has received notification from the U.S. Food and Drug Administration that its next generation SmartVest(R) Airway Clearance System, the model SQL(TM) has been cleared to market.
Electromed, Inc. Reports Fiscal Year 2013 Third Quarter Results
Business Wire - Tue May 14, 4:00PM CDT
Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended March 31, 2013. Net revenues for the three months ended March 31, 2013, were approximately $3,199,000, a 33.0% decrease compared to net revenues of approximately $4,774,000 for the same period last year. The Company also announced net loss of approximately $431,000, or $(0.05) per basic and diluted share, for the three months ended March 31, 2013, compared to net income of approximately $95,000 or $0.01 per basic and diluted share, for the same period last year. The decrease in net income primarily resulted from a decrease in homecare revenue partially offset by decreases in expenses. The decrease in homecare revenue was caused by downward pressure on pricing and added administrative procedures implemented by third party payers in the insurance claims process which has lengthened the approval process. Although total re
WEALTHMAKERS.COM Issues Bearish Research Reports on ELMD, NTAP, PKK, TREX
M2 - Mon Mar 25, 10:38AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Electromed Inc (NASDAQ:ELMD), NETAPP INCORPORATION (NASDAQ:NTAP), Peak Positioning Technologies Inc (NYSE
KK), Trex Company Inc (NYSE:TREX)
Electromed, Inc. Reports FY2013 Second Quarter Results
Business Wire - Wed Feb 13, 4:30PM CST
Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended December 31, 2012. Net revenues for the three months ended December 31, 2012, were approximately $3,856,000, a 19.5% decrease compared to net revenues of approximately $4,790,000 for the same period last year. The Company also announced net loss of approximately $411,000, or $0.05 per basic and diluted share, for the three months ended December 31, 2012, compared to net income of approximately $25,000, or $0.00 per basic and diluted share, for the same period last year. Net revenues decreased as a result of downward pressure on pricing and added administrative steps implemented by third party payers in the insurance claims process which has lengthened the approval process compared to the prior year. Net loss results were attributable to lower net revenues, offset by decreased expenses and operating efficiencies designe
Electromed reports planned departure of board member Darrel Kloeckner
M2 - Fri May 23, 5:34AM CDT
Electromed (NYSE MKT:ELMD), which manufactures, markets, and sells products that provide airway clearance therapy to patients with compromised pulmonary function, disclosed on Thursday that its board member Darrel Kloeckner will not stand for re-election at its 2014 Annual Meeting of Shareholders.
Electromed, Inc. Board Member Announces Plans to Step Down from Board
Business Wire - Thu May 22, 4:00PM CDT
Electromed, Inc. (NYSE MKT: ELMD) announced today that Darrel Kloeckner, a member of the Company's Board of Directors will not stand for reelection at the Company's 2014 Annual Meeting of Shareholders. Mr. Kloeckner has been a member of the Board since 2010.
Electromed, Inc. Reports Fiscal Year 2014 Second Quarter Results
Business Wire - Tue Feb 11, 8:00AM CST
Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the Company's second quarter of fiscal 2014.
Rudolph Technologies to Present at the Stifel Technology, Internet & Media Conference 2014
Business Wire - Tue Feb 04, 6:00AM CST
Rudolph Technologies, Inc. (NYSE: RTEC), a leading provider of process characterization equipment, lithography equipment and software for wafer fabs and advanced packaging facilities, today announced that the Company will present at the Stifel Technology, Internet & Media Conference 2014 at the Fairmont Hotel in San Francisco on February 11, 2014 at 9:10 am Pacific Standard Time. Steven Roth, Chief Financial Officer, will provide an overview of the Company and will discuss its competitive position and future prospects.
Electromed Down 10.5%, Shares Slide into the Red (ELMD)
Comtex SmarTrend(R) - Mon Jan 06, 11:44AM CST
Electromed (AMEX:ELMD) is one of today's worst performing low-priced stocks, down 10.5% to $2.30 on 1.1x average daily volume. Electromed has traded 322,000 shares thus far today, vs. average volume of 297,000 shares per day. The stock has underperformed the Dow (-10.5% to the Dow's -0.2%) and underperformed the S&P 500 (-10.5% to the S&P's -0.3%) during today's trading.
Electromed's SmartVest SQL receives US FDA market clearance
M2 - Tue Dec 31, 4:48AM CST
Electromed Inc (NYSE MKT: ELMD), a medical device company, on Monday announced that it has been notified by the US Food and Drug Administration that its next generation SmartVest Airway Clearance System, the model SQL, has been cleared to market.
Electromed, Inc. Receives FDA Market Clearance for the SmartVest(R) SQL(TM)
Business Wire - Mon Dec 30, 8:00AM CST
Electromed, Inc. (NYSE MKT: ELMD), a global medical device company, today announced it has received notification from the U.S. Food and Drug Administration that its next generation SmartVest(R) Airway Clearance System, the model SQL(TM) has been cleared to market.
Electromed, Inc. Reports Fiscal Year 2013 Third Quarter Results
Business Wire - Tue May 14, 4:00PM CDT
Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended March 31, 2013. Net revenues for the three months ended March 31, 2013, were approximately $3,199,000, a 33.0% decrease compared to net revenues of approximately $4,774,000 for the same period last year. The Company also announced net loss of approximately $431,000, or $(0.05) per basic and diluted share, for the three months ended March 31, 2013, compared to net income of approximately $95,000 or $0.01 per basic and diluted share, for the same period last year. The decrease in net income primarily resulted from a decrease in homecare revenue partially offset by decreases in expenses. The decrease in homecare revenue was caused by downward pressure on pricing and added administrative procedures implemented by third party payers in the insurance claims process which has lengthened the approval process. Although total re
WEALTHMAKERS.COM Issues Bearish Research Reports on ELMD, NTAP, PKK, TREX
M2 - Mon Mar 25, 10:38AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Electromed Inc (NASDAQ:ELMD), NETAPP INCORPORATION (NASDAQ:NTAP), Peak Positioning Technologies Inc (NYSE
KK), Trex Company Inc (NYSE:TREX) Electromed, Inc. Reports FY2013 Second Quarter Results
Business Wire - Wed Feb 13, 4:30PM CST
Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended December 31, 2012. Net revenues for the three months ended December 31, 2012, were approximately $3,856,000, a 19.5% decrease compared to net revenues of approximately $4,790,000 for the same period last year. The Company also announced net loss of approximately $411,000, or $0.05 per basic and diluted share, for the three months ended December 31, 2012, compared to net income of approximately $25,000, or $0.00 per basic and diluted share, for the same period last year. Net revenues decreased as a result of downward pressure on pricing and added administrative steps implemented by third party payers in the insurance claims process which has lengthened the approval process compared to the prior year. Net loss results were attributable to lower net revenues, offset by decreased expenses and operating efficiencies designe
